Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT1041230070
JPRN-jRCT1041230070
Recruiting
Phase 4

Observational Study of the Therapeutic Effects of Switching from GLP-1 Receptor Agonists to GLP-1/GIP Co- Receptor Agonists: Relationship to Patients' Eating Behavior Patterns

Yabe Daisuke0 sites90 target enrollmentAugust 18, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetesDiabetes Mellitus

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Diabetes
Sponsor
Yabe Daisuke
Enrollment
90
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 18, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Yabe Daisuke

Eligibility Criteria

Inclusion Criteria

  • •Patients with type 2 diabetes who have been switched from a GLP\-1 receptor agonist to a GLP\-1/GIP co\-receptor agonist, who understand the purpose of the study and give their consent

Exclusion Criteria

  • •1\) Patients who have difficulty following the instructions of the principal investigator or sub\-investigator
  • •2\) Other patients who are deemed inappropriate for this study by the principal investigator or sub\-investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Clinical Observation on the Therapeutic Effect of Tongjing Tiaozang Massage on Skeletal myopathy in type 2 diabetesSkeletal myopathy in type 2 diabetes
ITMCTR2024000134Changchun University of Chinese Medicine Affiliated Hospital
Not Yet Recruiting
N/A
Clinical Investigation of the Therapeutic Effect of Posterior Lumbar Interbody Fusion using Autologous Adipose tissue derived Stromal Vascular Fractio
KCT0009328Bundang CHA General Hospital10
Not Yet Recruiting
N/A
Effect of food products on thickened, white patches inside the mouthHealth Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue
CTRI/2021/05/033380M MOSHAHID ALAM RIZVI
Completed
Phase 2
Evaluation of the therapeutic effects of Iranian Traditional Medicine (Hab Shabyar) in patients with open-angle glaucoma: A double-blind clinical trialopen-angle glaucoma.Primary open-angle glaucoma
IRCT2016052828127N1Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences50
Recruiting
N/A
A retrospective study on the therapeutic effect of tocilizumab on COVID-19COVID-19
JPRN-UMIN000040614Japanese Red Cross Medical Center20